Dysregulation of Biomarkers of Hemostatic Activation and Inflammatory Processes are Associated with Adverse Outcomes in Pulmonary Embolism.

Iman Darwish Jawed Fareed Yevgeniy Brailovsky Debra Moorman Hoppensteadt Brett Slajus Emily Bontekoe Frank De StefanoTrent ReedAmir Darki

Published in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2022)

These studies suggest that various thrombo-inflammatory biomarkers are elevated in PE patients. Furthermore, L-selectin levels are inversely associated with mortality outcomes.

Keyphrases

pulmonary embolism
end stage renal disease
ejection fraction
inferior vena cava
newly diagnosed
oxidative stress
chronic kidney disease
peritoneal dialysis
prognostic factors
type diabetes
risk factors
cardiovascular disease
patient reported outcomes
metabolic syndrome
adipose tissue
insulin resistance